1 | Invitae | https://www.linkedin.com/company/invitae/ | United States | 2,524 | 505 | 20.01% | ▲ 145 |
2 | GRAIL | https://www.linkedin.com/company/grail-inc./ | United States | 1,060 | 207 | 19.53% | ▲ 24 |
3 | Apellis | https://www.linkedin.com/company/apellis/ | United States | 587 | 111 | 18.91% | ▲ 6 |
4 | NotCo | https://www.linkedin.com/company/the-not-co-/ | United States | 722 | 124 | 17.17% | ▲ 35 |
5 | Intellia Therapeutics | https://www.linkedin.com/company/intelliatx/ | United States | 580 | 99 | 17.07% | New Entry |
6 | Mirati Therapeutics | https://www.linkedin.com/company/mirati-therapeutics/ | United States | 521 | 86 | 16.51% | ▼ -4 |
7 | SOPHiA Genetics | https://www.linkedin.com/company/sophiagenetics/ | Switzerland | 536 | 86 | 16.04% | ▲ 31 |
8 | Veracyte | https://www.linkedin.com/company/veracyte/ | United States | 516 | 79 | 15.31% | ▲ 71 |
9 | AGQ Labs | https://www.linkedin.com/company/agq-labs/ | Spain | 593 | 90 | 15.18% | ▲ 60 |
10 | NanoString Technologies | https://www.linkedin.com/company/nanostring-technologies/ | United States | 799 | 119 | 14.89% | ▲ 53 |
11 | Biohaven | https://www.linkedin.com/company/biohaven-pharmaceuticals-inc/ | United States | 1,142 | 168 | 14.71% | ▲ 4 |
12 | Horizon | https://www.linkedin.com/company/horizontherapeutics/ | Ireland | 2,501 | 360 | 14.39% | ▲ 182 |
13 | Ambry Genetics | https://www.linkedin.com/company/ambry-genetics/ | United States | 747 | 107 | 14.32% | ▲ 62 |
14 | Caris Life Sciences | https://www.linkedin.com/company/caris-life-sciences/ | United States | 1,206 | 172 | 14.26% | ▲ 3 |
15 | Insmed | https://www.linkedin.com/company/insmed/ | United States | 662 | 94 | 14.20% | ▲ 172 |
16 | Beckman Coulter Life Sciences | https://www.linkedin.com/company/beckman-coulter-ls/ | United States | 1,766 | 250 | 14.16% | ▲ 2 |
17 | Alnylam Pharmaceuticals | https://www.linkedin.com/company/alnylam-pharmaceuticals/ | United States | 1,985 | 281 | 14.16% | ▲ 56 |
18 | Azenta Life Sciences | https://www.linkedin.com/company/azenta-life-sciences/ | United States | 957 | 132 | 13.79% | New Entry |
19 | CareDx | https://www.linkedin.com/company/care-dx-inc/ | United States | 696 | 95 | 13.65% | ▲ 88 |
20 | Myovant Sciences | https://www.linkedin.com/company/myovant-sciences/ | United States | 587 | 80 | 13.63% | ▲ 42 |
21 | PTC Therapeutics | https://www.linkedin.com/company/ptc-therapeutics/ | United States | 1,283 | 174 | 13.56% | ▲ 107 |
22 | Sage Therapeutics | https://www.linkedin.com/company/sage-therapeutics/ | United States | 638 | 86 | 13.48% | ▲ 30 |
23 | Artivion | https://www.linkedin.com/company/artivion/ | United States | 721 | 97 | 13.45% | New Entry |
24 | Ultragenyx Pharmaceutical | https://www.linkedin.com/company/ultragenyx-pharmaceutical-inc-/ | United States | 1,422 | 188 | 13.22% | ▲ 12 |
25 | argenx | https://www.linkedin.com/company/argenx/ | Belgium | 734 | 97 | 13.22% | ▲ 20 |
26 | Blueprint Medicines | https://www.linkedin.com/company/blueprint-medicines/ | United States | 598 | 79 | 13.21% | ▲ 175 |
27 | Kemin Industries | https://www.linkedin.com/company/kemin-industries/ | United States | 1,675 | 221 | 13.19% | ▲ 102 |
28 | mAbxience | https://www.linkedin.com/company/mabxience/ | Spain | 660 | 87 | 13.18% | ▲ 5 |
29 | Genmab | https://www.linkedin.com/company/genmab/ | Denmark | 1,513 | 198 | 13.09% | ▲ 28 |
30 | Bavarian Nordic | https://www.linkedin.com/company/bavariannordic/ | Denmark | 813 | 105 | 12.92% | ▲ 13 |
31 | Twist Bioscience | https://www.linkedin.com/company/twist-bioscience/ | United States | 885 | 114 | 12.88% | ▲ 28 |
32 | Miltenyi Biotec | https://www.linkedin.com/company/miltenyi-biotec/ | Germany | 2,192 | 280 | 12.77% | ▲ 72 |
33 | ConcertAI | https://www.linkedin.com/company/concertai/ | United States | 558 | 71 | 12.72% | New Entry |
34 | Precision For Medicine | https://www.linkedin.com/company/precision-for-medicine/ | United States | 1,075 | 136 | 12.65% | ▲ 58 |
35 | Roche Middle East | https://www.linkedin.com/company/roche-middle-east/ | International | 594 | 74 | 12.46% | New Entry |
36 | FUJIFILM Diosynth Biotechnologies | https://www.linkedin.com/company/fujifilm-diosynth-biotechnologies/ | United Kingdom | 3,294 | 408 | 12.39% | ▲ 173 |
37 | Oxford Nanopore Technologies | https://www.linkedin.com/company/oxford-nanopore-technologies/ | United Kingdom | 800 | 99 | 12.38% | ▲ 112 |
38 | KBI Biopharma | https://www.linkedin.com/company/kbi-biopharma/ | United States | 1,369 | 165 | 12.05% | ▲ 255 |
39 | Merck Life Science | https://www.linkedin.com/company/merck-life-science/ | Germany | 6,034 | 715 | 11.85% | ▲ 76 |
40 | Ginkgo Bioworks | https://www.linkedin.com/company/ginkgo-bioworks/ | United States | 902 | 106 | 11.75% | ▼ -26 |
41 | Bruker Daltonics | https://www.linkedin.com/company/bruker-daltonics/ | United States | 775 | 91 | 11.74% | ▲ 57 |
42 | Ascendis Pharma | https://www.linkedin.com/company/ascendis-pharma-a-s/ | Denmark | 724 | 85 | 11.74% | ▲ 40 |
43 | Natera | https://www.linkedin.com/company/natera/ | United States | 2,738 | 321 | 11.72% | ▲ 41 |
44 | The Binding Site | https://www.linkedin.com/company/the-binding-site-group-ltd/ | United Kingdom | 857 | 100 | 11.67% | ▲ 201 |
45 | Alvotech | https://www.linkedin.com/company/alvotechpr/ | Iceland | 664 | 77 | 11.60% | ▲ 158 |
46 | Foundation Medicine | https://www.linkedin.com/company/foundation-medicine/ | United States | 1,879 | 216 | 11.50% | ▲ 34 |
47 | Neogen Corporation | https://www.linkedin.com/company/neogen-corporation/ | United States | 1,480 | 169 | 11.42% | ▲ 180 |
48 | Cue Health | https://www.linkedin.com/company/cuehealthinc/ | United States | 1,039 | 118 | 11.36% | ▲ 94 |
49 | Epredia | https://www.linkedin.com/company/epredia/ | United States | 653 | 74 | 11.33% | ▲ 15 |
50 | Galapagos | https://www.linkedin.com/company/glpg/ | Belgium | 1,465 | 166 | 11.33% | ▲ 103 |
51 | Amyris | https://www.linkedin.com/company/amyris-inc/ | United States | 1,285 | 145 | 11.28% | ▲ 101 |
52 | Alexion Pharmaceuticals | https://www.linkedin.com/company/alexion-pharmaceuticals/ | United States | 3,984 | 449 | 11.27% | ▲ 110 |
53 | Corbion | https://www.linkedin.com/company/corbion/ | Netherlands | 2,052 | 231 | 11.26% | ▲ 68 |
54 | Resilience | https://www.linkedin.com/company/weareresilience/ | United States | 1,507 | 169 | 11.21% | ▼ -35 |
55 | Tempus Labs | https://www.linkedin.com/company/tempuslabs/ | United States | 1,618 | 180 | 11.12% | ▲ 88 |
56 | MedGenome | https://www.linkedin.com/company/medgenomelabs/ | United States | 585 | 65 | 11.11% | ▲ 159 |
57 | Illumina | https://www.linkedin.com/company/illumina/ | United States | 9,142 | 1,013 | 11.08% | ▲ 32 |
58 | Repligen | https://www.linkedin.com/company/repligen-corporation/ | United States | 976 | 108 | 11.07% | ▲ 90 |
59 | Moderna | https://www.linkedin.com/company/modernatx/ | United States | 3,873 | 427 | 11.03% | ▲ 12 |
60 | GBT | https://www.linkedin.com/company/global-blood-therapeutics/ | United States | 554 | 61 | 11.01% | ▼ -32 |
61 | Advanced Clinical | https://www.linkedin.com/company/advanced-clinical/ | United States | 845 | 93 | 11.01% | New Entry |
62 | DiaSorin | https://www.linkedin.com/company/diasorin/ | Italy | 1,591 | 175 | 11.00% | ▲ 68 |
63 | CellCarta | https://www.linkedin.com/company/cellcarta/ | Canada | 557 | 61 | 10.95% | ▼ -36 |
64 | Valneva | https://www.linkedin.com/company/valneva/ | France | 677 | 74 | 10.93% | ▼ -29 |
65 | Amicus Therapeutics | https://www.linkedin.com/company/amicus-therapeutics/ | United States | 561 | 61 | 10.87% | ▲ 51 |
66 | BioNTech | https://www.linkedin.com/company/biontech-se/ | Germany | 2,267 | 245 | 10.81% | ▲ 102 |
67 | Chr. Hansen | https://www.linkedin.com/company/chr-hansen-as/ | Denmark | 3,297 | 356 | 10.80% | ▲ 20 |
68 | STEMCELL Technologies | https://www.linkedin.com/company/stemcell-technologies/ | Canada | 1,526 | 164 | 10.75% | ▲ 4 |
69 | MilliporeSigma | https://www.linkedin.com/company/milliporesigma/ | United States | 5,507 | 590 | 10.71% | ▲ 55 |
70 | PacBio | https://www.linkedin.com/company/pacbio/ | United States | 742 | 79 | 10.65% | ▲ 23 |
71 | Sartorius | https://www.linkedin.com/company/sartorius/ | Germany | 7,842 | 834 | 10.64% | ▲ 38 |
72 | bioMérieux | https://www.linkedin.com/company/biomerieux/ | France | 9,967 | 1,051 | 10.54% | ▲ 68 |
73 | Spark Therapeutics | https://www.linkedin.com/company/spark-therapeutics-inc/ | United States | 943 | 99 | 10.50% | ▲ 93 |
74 | Adaptimmune | https://www.linkedin.com/company/adaptimmune/ | United Kingdom | 546 | 57 | 10.44% | ▼ -32 |
75 | Polpharma Biologics | https://www.linkedin.com/company/polpharmabiologics/ | Poland | 752 | 78 | 10.37% | ▲ 215 |
76 | Bruker | https://www.linkedin.com/company/bruker-corporation/ | United States | 3,726 | 384 | 10.31% | ▲ 91 |
77 | Myriad Genetics | https://www.linkedin.com/company/myriad-genetics/ | United States | 2,196 | 226 | 10.29% | ▲ 164 |
78 | Abzena | https://www.linkedin.com/company/abzena/ | United Kingdom | 562 | 57 | 10.14% | ▲ 55 |
79 | MiMedx | https://www.linkedin.com/company/mimedx/ | United States | 751 | 76 | 10.12% | ▲ 55 |
80 | CST | https://www.linkedin.com/company/cell-signaling-technology/ | United States | 593 | 60 | 10.12% | ▲ 33 |
81 | Sarepta Therapeutics | https://www.linkedin.com/company/sarepta-therapeutics/ | United States | 1,055 | 106 | 10.05% | ▲ 130 |
82 | Qiagen | https://www.linkedin.com/company/qiagen/ | Germany | 4,684 | 469 | 10.01% | ▲ 82 |
83 | PerkinElmer | https://www.linkedin.com/company/perkinelmer/ | United States | 7,746 | 762 | 9.84% | ▲ 61 |
84 | Integrated DNA Technologies | https://www.linkedin.com/company/integrated-dna-technologies/ | United States | 1,465 | 144 | 9.83% | ▲ 169 |
85 | Guardant Health | https://www.linkedin.com/company/guardanthealth/ | United States | 2,150 | 211 | 9.81% | ▲ 1 |
86 | Eppendorf Group | https://www.linkedin.com/company/eppendorf/ | Germany | 2,507 | 243 | 9.69% | ▲ 89 |
87 | Cepheid | https://www.linkedin.com/company/cepheid/ | United States | 5,038 | 476 | 9.45% | ▲ 39 |
88 | Molecular Devices | https://www.linkedin.com/company/molecular-devices/ | United States | 776 | 73 | 9.41% | ▲ 81 |
89 | Seagen | https://www.linkedin.com/company/seagen/ | United States | 3,057 | 287 | 9.39% | ▲ 19 |
90 | Sartorius Stedim Biotech | https://www.linkedin.com/company/sartorius-stedim-biotech/ | France | 3,482 | 325 | 9.33% | ▲ 47 |
91 | Kite Pharma | https://www.linkedin.com/company/kite-pharma-inc-/ | United States | 3,269 | 303 | 9.27% | ▲ 122 |
92 | Phenomenex | https://www.linkedin.com/company/phenomenex/ | United States | 669 | 62 | 9.27% | ▲ 27 |
93 | BioAgilytix | https://www.linkedin.com/company/bioagilytix/ | United States | 821 | 76 | 9.26% | ▲ 2 |
94 | Biogen | https://www.linkedin.com/company/biogen-/ | United States | 9,453 | 872 | 9.22% | ▲ 64 |
95 | Adaptive Biotechnologies | https://www.linkedin.com/company/adaptive-biotechnologies-corp-/ | United States | 759 | 70 | 9.22% | ▼ -30 |
96 | 23andMe | https://www.linkedin.com/company/23andme/ | United States | 788 | 72 | 9.14% | ▲ 88 |
97 | Novartis Gene Therapies | https://www.linkedin.com/company/novartis-gene-therapies/ | United States | 1,048 | 95 | 9.06% | ▲ 91 |
98 | Shimadzu | https://www.linkedin.com/company/shimadzu-scientific-instruments/ | United States | 607 | 55 | 9.06% | ▲ 72 |
99 | SCIEX | https://www.linkedin.com/company/sciex/ | United States | 2,559 | 229 | 8.95% | ▼ -2 |
100 | Emergent BioSolutions | https://www.linkedin.com/company/emergent-biosolutions/ | United States | 2,294 | 205 | 8.94% | ▲ 149 |
101 | Bio-Techne | https://www.linkedin.com/company/bio-techne/ | United States | 2,474 | 221 | 8.93% | ▲ 139 |
102 | New England Biolabs | https://www.linkedin.com/company/new-england-biolabs/ | United States | 643 | 57 | 8.86% | ▲ 94 |
103 | Tecan | https://www.linkedin.com/company/tecan/ | Switzerland | 1,652 | 146 | 8.84% | ▲ 169 |
104 | Sema4 | https://www.linkedin.com/company/sema4genomics/ | United States | 978 | 86 | 8.79% | ▲ 52 |
105 | Bruker BioSpin | https://www.linkedin.com/company/bruker-biospin/ | United States | 981 | 86 | 8.77% | ▲ 94 |
106 | BeiGene | https://www.linkedin.com/company/beigene/ | United States | 2,751 | 241 | 8.76% | ▲ 125 |
107 | Vertex Pharmaceuticals | https://www.linkedin.com/company/vertex-pharmaceuticals/ | United States | 4,126 | 361 | 8.75% | ▲ 115 |
108 | Hamilton Bonaduz | https://www.linkedin.com/company/hamilton-bonaduz-ag/ | Switzerland | 540 | 47 | 8.70% | ▼ -27 |
109 | Exact Sciences | https://www.linkedin.com/company/exact-sciences/ | United States | 5,100 | 440 | 8.63% | ▲ 89 |
110 | Fluidigm | https://www.linkedin.com/company/fluidigm-corporation/ | United States | 553 | 47 | 8.50% | ▲ 8 |
111 | AGC Biologics | https://www.linkedin.com/company/agcbiologics/ | United States | 2,156 | 183 | 8.49% | ▲ 89 |
112 | Waters Corporation | https://www.linkedin.com/company/waters/ | United States | 6,872 | 582 | 8.47% | New Entry |
113 | MorphoSys | https://www.linkedin.com/company/morphosys/ | Germany | 685 | 58 | 8.47% | ▲ 131 |
114 | Revance | https://www.linkedin.com/company/revance/ | United States | 513 | 43 | 8.38% | New Entry |
115 | Luminex Corporation | https://www.linkedin.com/company/luminex-corporation/ | United States | 1,100 | 92 | 8.36% | ▲ 76 |
116 | Mérieux NutriSciences | https://www.linkedin.com/company/chelab-laboratories/ | Italy | 802 | 67 | 8.35% | ▲ 65 |
117 | Aldevron | https://www.linkedin.com/company/aldevron/ | United States | 687 | 57 | 8.30% | ▲ 106 |
118 | Verily | https://www.linkedin.com/company/verily/ | United States | 1,447 | 120 | 8.29% | New Entry |
119 | Biotechnology Innovation Organization | https://www.linkedin.com/company/biotechnology-innovation-organization/ | United States | 592 | 49 | 8.28% | New Entry |
120 | Alltech | https://www.linkedin.com/company/alltech/ | United States | 2,542 | 210 | 8.26% | ▼ -37 |
121 | Novozymes | https://www.linkedin.com/company/novozymes/ | Denmark | 5,503 | 446 | 8.10% | ▲ 87 |
122 | LGC | https://www.linkedin.com/company/lgcgroup/ | United Kingdom | 2,479 | 198 | 7.99% | ▲ 144 |
123 | Atara Biotherapeutics | https://www.linkedin.com/company/atarabio/ | United States | 539 | 43 | 7.98% | ▼ -75 |
124 | Esco | https://www.linkedin.com/company/esco-micro-pte-ltd/ | Singapore | 672 | 53 | 7.89% | New Entry |
125 | Oxford Biomedica | https://www.linkedin.com/company/oxford-biomedica/ | United Kingdom | 753 | 59 | 7.84% | ▼ -19 |
126 | Promega Corporation | https://www.linkedin.com/company/promega/ | United States | 1,636 | 128 | 7.82% | ▲ 19 |
127 | Thermo Fisher Scientific | https://www.linkedin.com/company/thermo-fisher-scientific/ | United States | 70,769 | 5,500 | 7.77% | ▲ 93 |
128 | GenScript | https://www.linkedin.com/company/genscript-corporation/ | United States | 890 | 69 | 7.75% | ▲ 110 |
129 | Gilead Sciences | https://www.linkedin.com/company/gilead-sciences/ | United States | 14,129 | 1,095 | 7.75% | ▲ 114 |
130 | Organogenesis | https://www.linkedin.com/company/organogenesis/ | United States | 970 | 74 | 7.63% | ▲ 35 |
131 | 10x Genomics | https://www.linkedin.com/company/10xgenomics/ | United States | 1,927 | 146 | 7.58% | ▼ -82 |
132 | ATCC | https://www.linkedin.com/company/atcc/ | United States | 715 | 54 | 7.55% | ▲ 107 |
133 | Legend Biotech | https://www.linkedin.com/company/legendbiotechco./ | United States | 650 | 49 | 7.54% | ▲ 53 |
134 | Bio-Rad Laboratories | https://www.linkedin.com/company/bio-rad/ | United States | 7,879 | 592 | 7.51% | ▲ 112 |
135 | Avantor | https://www.linkedin.com/company/avantorinc/ | United States | 9,626 | 721 | 7.49% | ▲ 152 |
136 | Medicago | https://www.linkedin.com/company/medicago/ | Canada | 608 | 45 | 7.40% | ▼ -116 |
137 | Regeneron | https://www.linkedin.com/company/regeneron-pharmaceuticals/ | United States | 11,561 | 855 | 7.40% | ▲ 97 |
138 | Neurocrine Biosciences | https://www.linkedin.com/company/neurocrine-biosciences/ | United States | 1,130 | 83 | 7.35% | ▲ 35 |
139 | Selvita | https://www.linkedin.com/company/selvita/ | Poland | 559 | 41 | 7.33% | ▲ 136 |
140 | Groupe CARSO | https://www.linkedin.com/company/groupe-carso/ | France | 786 | 57 | 7.25% | ▲ 188 |
141 | Lonza | https://www.linkedin.com/company/lonza/ | Switzerland | 14,214 | 1,024 | 7.20% | ▲ 84 |
142 | MSD | https://www.linkedin.com/company/meso-scale-diagnostics/ | United States | 695 | 50 | 7.19% | ▲ 172 |
143 | The Jackson Laboratory | https://www.linkedin.com/company/the-jackson-laboratory/ | United States | 1,942 | 139 | 7.16% | ▲ 124 |
144 | Idexx | https://www.linkedin.com/company/idexx-laboratories/ | United States | 6,748 | 480 | 7.11% | ▲ 124 |
145 | LGC Biosearch Technologies | https://www.linkedin.com/company/lgc-biosearch-technologies/ | United Kingdom | 776 | 55 | 7.09% | ▲ 102 |
146 | DSM | https://www.linkedin.com/company/dsm/ | Netherlands | 16,148 | 1,143 | 7.08% | New Entry |
147 | Agilent Technologies | https://www.linkedin.com/company/agilent-technologies/ | United States | 17,728 | 1,251 | 7.06% | ▲ 206 |
148 | Pall Corporation | https://www.linkedin.com/company/pall-corporation/ | United States | 7,141 | 500 | 7.00% | ▲ 59 |
149 | MP Biomedicals | https://www.linkedin.com/company/mp-biomedicals/ | United States | 557 | 39 | 7.00% | ▲ 136 |
150 | BioMarin | https://www.linkedin.com/company/biomarin/ | United States | 3,005 | 210 | 6.99% | ▲ 85 |
151 | CureVac | https://www.linkedin.com/company/curevac/ | Germany | 661 | 46 | 6.96% | ▲ 85 |
152 | Ajinomoto Bio-Pharma Services | https://www.linkedin.com/company/ajibio-pharma-services/ | United States | 623 | 43 | 6.90% | ▲ 77 |
153 | EMD Serono | https://www.linkedin.com/company/emd-serono-inc/ | United States | 2,015 | 136 | 6.75% | ▲ 77 |
154 | Charles River Laboratories | https://www.linkedin.com/company/charles-river-laboratories/ | United States | 13,335 | 881 | 6.61% | ▲ 107 |
155 | Rentschler Biopharma | https://www.linkedin.com/company/rentschler-biopharma-se/ | Germany | 593 | 39 | 6.58% | ▲ 95 |
156 | Novotech | https://www.linkedin.com/company/novotech/ | Australia | 1,481 | 97 | 6.55% | ▲ 68 |
157 | Hamilton Company | https://www.linkedin.com/company/hamilton-company/ | United States | 905 | 59 | 6.52% | ▲ 25 |
158 | Ionis | https://www.linkedin.com/company/ionis-pharmaceuticals/ | United States | 795 | 49 | 6.16% | ▲ 160 |
159 | Alkermes | https://www.linkedin.com/company/alkermes/ | Ireland | 2,338 | 144 | 6.16% | ▲ 58 |
160 | Exelixis | https://www.linkedin.com/company/exelixis/ | United States | 1,192 | 72 | 6.04% | ▲ 129 |
161 | Premier Research | https://www.linkedin.com/company/premier-research/ | United States | 2,287 | 138 | 6.03% | ▲ 96 |
162 | Amgen | https://www.linkedin.com/company/amgen/ | United States | 29,054 | 1,725 | 5.94% | ▲ 107 |
163 | Roche | https://www.linkedin.com/company/roche/ | Switzerland | 97,404 | 5,500 | 5.65% | ▲ 128 |
164 | bluebird bio | https://www.linkedin.com/company/bluebirdbio/ | United States | 604 | 34 | 5.63% | ▼ -1 |
165 | CSL Behring | https://www.linkedin.com/company/csl-behring/ | United States | 7,309 | 410 | 5.61% | ▲ 95 |
166 | Abcam | https://www.linkedin.com/company/abcam/ | United Kingdom | 2,282 | 126 | 5.52% | ▲ 98 |
167 | ABS Global | https://www.linkedin.com/company/absglobal/ | United States | 569 | 31 | 5.45% | New Entry |
168 | VWR | https://www.linkedin.com/company/vwr/ | United States | 5,197 | 273 | 5.25% | ▲ 133 |
169 | BioTel Heart | https://www.linkedin.com/company/biotelheart/ | United States | 557 | 29 | 5.21% | ▲ 167 |
170 | CRISPR Therapeutics | https://www.linkedin.com/company/crispr-therapeutics/ | United States | 532 | 27 | 5.08% | ▲ 20 |
171 | Mérieux NutriSciences | https://www.linkedin.com/company/mxnsna/ | United States | 811 | 39 | 4.81% | ▲ 168 |
172 | Eurofins Lancaster Laboratories | https://www.linkedin.com/company/lancaster-laboratories/ | United States | 2,935 | 135 | 4.60% | ▲ 150 |
173 | CSL | https://www.linkedin.com/company/csl/ | Australia | 16,603 | 755 | 4.55% | ▲ 131 |
174 | Genentech | https://www.linkedin.com/company/genentech/ | United States | 20,290 | 839 | 4.14% | ▲ 155 |
175 | BioLegend | https://www.linkedin.com/company/biolegend/ | United States | 610 | 25 | 4.10% | ▲ 132 |
176 | Millennium Health | https://www.linkedin.com/company/millennium-health/ | United States | 522 | 21 | 4.02% | ▲ 151 |
177 | Dendreon | https://www.linkedin.com/company/dendreon/ | United States | 661 | 26 | 3.93% | ▲ 117 |
178 | Eurofins | https://www.linkedin.com/company/eurofins/ | Luxembourg | 20,368 | 800 | 3.93% | ▲ 41 |
179 | Pharming | https://www.linkedin.com/company/pharming/ | Netherlands | 796 | 31 | 3.89% | ▲ 153 |
180 | Euroimmun | https://www.linkedin.com/company/euroimmun-a-perkinelmer-company/ | Germany | 532 | 20 | 3.76% | ▲ 132 |
181 | Rho | https://www.linkedin.com/company/rhoworld/ | United States | 645 | 24 | 3.72% | New Entry |
182 | Forensic Science Laboratory | https://www.linkedin.com/company/forensic-science-laboratory/ | United States | 608 | 21 | 3.45% | ▲ 149 |
183 | BioReliance | https://www.linkedin.com/company/bioreliance/ | United States | 609 | 19 | 3.12% | ▲ 126 |
184 | Baxalta | https://www.linkedin.com/company/baxalta/ | United States | 580 | 15 | 2.59% | ▲ 176 |
185 | BIOCON | https://www.linkedin.com/company/biocon-limited/ | United Kingdom | 608 | 15 | 2.47% | New Entry |
186 | Nektar Therapeutics | https://www.linkedin.com/company/nektar-therapeutics/ | United States | 867 | 20 | 2.31% | New Entry |
187 | BPL Plasma | https://www.linkedin.com/company/bpl-plasma/ | United States | 899 | 19 | 2.11% | ▲ 170 |
188 | Patheon | https://www.linkedin.com/company/patheon/ | United States | 2,627 | 51 | 1.94% | New Entry |
189 | Sigma-Aldrich | https://www.linkedin.com/company/sigma-aldrich/ | United States | 3,678 | 71 | 1.93% | ▲ 169 |
190 | Ventana Medical Systems | https://www.linkedin.com/company/ventana-medical-systems/ | United States | 984 | 16 | 1.63% | ▲ 172 |
191 | Hologic | https://www.linkedin.com/company/gen-probe-incorporated/ | United States | 567 | 9 | 1.59% | ▲ 163 |
192 | VA Boston Healthcare System | https://www.linkedin.com/company/va-boston-healthcare-system/ | United States | 702 | 11 | 1.57% | New Entry |
193 | The National Institutes of Health | https://www.linkedin.com/company/national-institutes-of-health/ | United States | 26,186 | 393 | 1.50% | New Entry |
194 | Dow AgroSciences | https://www.linkedin.com/company/dow-agrosciences/ | United States | 3,731 | 48 | 1.29% | ▲ 170 |
195 | Mahyco Seeds | https://www.linkedin.com/company/mahyco-seeds-ltd./ | United States | 537 | 6 | 1.12% | ▲ 180 |
196 | Life Technologies | https://www.linkedin.com/company/life_technologies/ | United States | 3,875 | 43 | 1.11% | ▲ 175 |
197 | Roche NimbleGen | https://www.linkedin.com/company/roche-nimblegen-inc/ | United States | 601 | 6 | 1.00% | New Entry |
198 | R&D Systems | https://www.linkedin.com/company/r&d-systems/ | United States | 638 | 6 | 0.94% | ▲ 174 |
199 | Brooks Life Sciences | https://www.linkedin.com/company/brookslifesciences/ | United States | 670 | 5 | 0.75% | New Entry |
200 | MedImmune | https://www.linkedin.com/company/medimmune/ | United States | 1,636 | 9 | 0.55% | ▲ 166 |
201 | Elan Pharmaceuticals | https://www.linkedin.com/company/elan-pharmaceuticals/ | Ireland | 626 | 3 | 0.48% | ▲ 182 |
202 | Centocor | https://www.linkedin.com/company/centocor/ | United States | 858 | 3 | 0.35% | ▲ 182 |
203 | Genzyme Genetics | https://www.linkedin.com/company/genzyme-genetics/ | United States | 773 | 2 | 0.26% | ▲ 175 |
204 | Human Genome Sciences | https://www.linkedin.com/company/human-genome-sciences/ | United States | 551 | 1 | 0.18% | ▲ 184 |
205 | CV Therapeutics | https://www.linkedin.com/company/cv-therapeutics/ | United States | 565 | 0 | 0.00% | ▲ 188 |